ACM
NVO

Argentus Capital Management’s Novo Nordisk NVO Stock Holding History

Argentus Capital Management’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-660
Closed -$18K – 618
2016
Q2 		$18K Buy
+660
New +$18.1K 0.01% 507

Other funds holding NVO

Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return

Argentus Capital Management's NVO Position: Q3 2016 in Review

Argentus Capital Management sold out of Novo Nordisk (NVO) in Q3 2016, closing a stake of 660 shares — an estimated $18K sold.

Argentus Capital Management first reported a position in NVO in Q2 2016 and held it in 1 quarter. The position peaked at $18K in Q2 2016. 511 funds tracked by Wall St. Rank hold NVO as of Q3 2016.

  • Argentus Capital Management reported no remaining Novo Nordisk position as of Q3 2016 after selling out during the quarter.
  • Argentus Capital Management sold 660 Novo Nordisk shares in Q3 2016, an estimated $18K.
  • Argentus Capital Management first reported a position in Novo Nordisk in Q2 2016 and held it in 1 quarter.
  • Argentus Capital Management's Novo Nordisk position peaked at $18K in Q2 2016.
  • 511 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2016.

Based on Argentus Capital Management's 13F filing for Q3 2016, filed 1 Nov 2016.